Mendelian Disorders Testing Market Size to Reach USD 7.8 Billion by 2032 | Growth Trends & Insights Global Mendelian disorders testing market is gaining strong momentum as healthcare systems worldwide intensify their focus on early diagnosis, preventive screening, and precision medicine. The market is projected to expand from USD 4.6 billion in 2025 to USD 7.8 billion by 2032, registering a robust compound annual growth rate (CAGR) of 7.8% during the forecast period. This sustained growth reflects rising awareness of inherited diseases, expanding newborn and prenatal screening programs, and rapid advancements in genomic testing technologies. Access the market report https://www.24lifesciences.com/mendelian-disorders-testing-market-9526